NCT04187131 An Augmented Reality Based System for Neglect Detection, Assessment, and Rehabilitation
| NCT ID | NCT04187131 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2028-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2023-06-01 with a primary completion date of 2028-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this phase is to examine the feasibility and acceptability of the Augmented Reality (AR)-based and electroencephalography (EEG)-based neglect detection and rehabilitation tool.
Eligibility Criteria
Inclusion Criteria: * ages18 and older * acute stroke * admitted to inpatient rehabilitation * presence of neglect (Behavioral Inattention Test total score \<129, or scoring below pre-defined cutoff score in at least one of the six subtests) * more than 10/% missed targets on the Augmented Reality Screening Test * intact vibration (positive test on Vibration Sensation Test) * intact auditory function (positive test on Auditory Sensation Test) * English speaking Exclusion Criteria: * inability to follow one-step directions at least 80% of the time * current diagnosis of dementia, Parkinson's disease, multiple sclerosis, or space-occupying tumor * metal in the head that causes interference with the EEG system * self-report of previous positive photic stimulation test
Contact & Investigator
Murat Akcakaya, PhD
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT04187131 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04187131 currently recruiting?
Yes, NCT04187131 is actively recruiting participants. Contact the research team at akcakaya@pitt.edu for enrollment information.
Where is the NCT04187131 trial being conducted?
This trial is being conducted at Boston, United States, Pittsburgh, United States.
Who is sponsoring the NCT04187131 clinical trial?
NCT04187131 is sponsored by University of Pittsburgh. The principal investigator is Murat Akcakaya, PhD at University of Pittsburgh. The trial plans to enroll 10 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.